HEADER IMMUNE SYSTEM 28-AUG-23 8TZW TITLE CRYSTAL STRUCTURE OF 10E8-GT4 SCAFFOLD IN COMPLEX WITH A HUMAN 10E8 TITLE 2 INFERRED GERMLINE (10E8-IGL1) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 10E8-IGL1 FAB HEAVY CHAIN; COMPND 3 CHAIN: H; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: 10E8-IGL1 FAB LIGHT CHAIN; COMPND 7 CHAIN: L; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: 10E8-GT4 EPITOPE SCAFFOLD; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: FREESTYLE 293F; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PHLSEC; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 16 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 18 EXPRESSION_SYSTEM_CELL_LINE: FREESTYLE 293F; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PHLSEC; SOURCE 21 MOL_ID: 3; SOURCE 22 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 23 ORGANISM_COMMON: HUMAN; SOURCE 24 ORGANISM_TAXID: 9606; SOURCE 25 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 26 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 27 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 28 EXPRESSION_SYSTEM_CELL_LINE: FREESTYLE 293F; SOURCE 29 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 30 EXPRESSION_SYSTEM_PLASMID: PHLSEC KEYWDS VACCINE, BROADLY NEUTRALIZING ANTIBODY, HIV, GP41, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.IRIMIA,I.A.WILSON REVDAT 3 09-OCT-24 8TZW 1 REMARK REVDAT 2 19-JUN-24 8TZW 1 JRNL REVDAT 1 12-JUN-24 8TZW 0 JRNL AUTH T.SCHIFFNER,I.PHUNG,R.RAY,A.IRIMIA,M.TIAN,O.SWANSON,J.H.LEE, JRNL AUTH 2 C.D.LEE,E.MARINA-ZARATE,S.Y.CHO,J.HUANG,G.OZOROWSKI, JRNL AUTH 3 P.D.SKOG,A.M.SERRA,K.RANTALAINEN,J.D.ALLEN,S.BABOO, JRNL AUTH 4 O.L.RODRIGUEZ,S.HIMANSU,J.ZHOU,J.HURTADO,C.T.FLYNN, JRNL AUTH 5 K.MCKENNEY,C.HAVENAR-DAUGHTON,S.SAHA,K.SHIELDS,S.SCHULZE, JRNL AUTH 6 M.L.SMITH,C.H.LIANG,L.TOY,S.PECETTA,Y.C.LIN,J.R.WILLIS, JRNL AUTH 7 F.SESTERHENN,D.W.KULP,X.HU,C.A.COTTRELL,X.ZHOU,J.RUIZ, JRNL AUTH 8 X.WANG,U.NAIR,K.H.KIRSCH,H.L.CHENG,J.DAVIS,O.KALYUZHNIY, JRNL AUTH 9 A.LIGUORI,J.K.DIEDRICH,J.T.NGO,V.LEWIS,N.PHELPS,R.D.TINGLE, JRNL AUTH10 S.SPENCER,E.GEORGESON,Y.ADACHI,M.KUBITZ,S.ESKANDARZADEH, JRNL AUTH11 M.A.ELSLIGER,R.R.AMARA,E.LANDAIS,B.BRINEY,D.R.BURTON, JRNL AUTH12 D.G.CARNATHAN,G.SILVESTRI,C.T.WATSON,J.R.YATES 3RD, JRNL AUTH13 J.C.PAULSON,M.CRISPIN,G.GRIGORYAN,A.B.WARD,D.SOK,F.W.ALT, JRNL AUTH14 I.A.WILSON,F.D.BATISTA,S.CROTTY,W.R.SCHIEF JRNL TITL VACCINATION INDUCES BROADLY NEUTRALIZING ANTIBODY PRECURSORS JRNL TITL 2 TO HIV GP41. JRNL REF NAT.IMMUNOL. V. 25 1073 2024 JRNL REFN ESSN 1529-2916 JRNL PMID 38816615 JRNL DOI 10.1038/S41590-024-01833-W REMARK 2 REMARK 2 RESOLUTION. 2.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.21RC1_5058 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.70 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.4 REMARK 3 NUMBER OF REFLECTIONS : 19771 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.950 REMARK 3 FREE R VALUE TEST SET COUNT : 978 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.7000 - 5.0100 0.98 2879 147 0.1885 0.2129 REMARK 3 2 5.0100 - 3.9800 0.96 2752 144 0.1799 0.2078 REMARK 3 3 3.9800 - 3.4800 0.98 2800 151 0.2263 0.3124 REMARK 3 4 3.4800 - 3.1600 0.94 2711 140 0.2480 0.3076 REMARK 3 5 3.1600 - 2.9300 0.96 2728 148 0.2886 0.3388 REMARK 3 6 2.9300 - 2.7600 0.97 2770 136 0.2997 0.3627 REMARK 3 7 2.7600 - 2.6600 0.76 2153 112 0.3188 0.4222 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.399 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.416 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 66.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4687 REMARK 3 ANGLE : 0.524 6397 REMARK 3 CHIRALITY : 0.043 720 REMARK 3 PLANARITY : 0.004 829 REMARK 3 DIHEDRAL : 17.421 1679 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 149.6581 53.1855 17.8960 REMARK 3 T TENSOR REMARK 3 T11: 0.4523 T22: 0.3977 REMARK 3 T33: 0.4373 T12: -0.0620 REMARK 3 T13: 0.0094 T23: -0.0344 REMARK 3 L TENSOR REMARK 3 L11: 2.0910 L22: -0.2093 REMARK 3 L33: 0.3547 L12: -0.0406 REMARK 3 L13: -0.1952 L23: -0.0078 REMARK 3 S TENSOR REMARK 3 S11: -0.0383 S12: -0.2181 S13: -0.1615 REMARK 3 S21: -0.0007 S22: -0.0399 S23: 0.0272 REMARK 3 S31: 0.0470 S32: -0.1479 S33: -0.0029 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8TZW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1000276985. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19803 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.660 REMARK 200 RESOLUTION RANGE LOW (A) : 31.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.72000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.72 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10% GLYCEROL, 0.1 M HEPES PH 7.5 5% REMARK 280 PEG 3000, 30% PEG 400, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 35.49400 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS H 43 CE NZ REMARK 470 LYS H 147 CG CD CE NZ REMARK 470 SER H 150 OG REMARK 470 LYS L 131 CD CE NZ REMARK 470 LYS L 168 CG CD CE NZ REMARK 470 GLU L 212 CG CD OE1 OE2 REMARK 470 GLU C 103 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLN H 189 OG SER H 195 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS H 147 -33.20 -168.58 REMARK 500 ASP H 162 76.73 58.66 REMARK 500 SER H 206 43.24 -94.59 REMARK 500 THR H 209 -62.46 -104.83 REMARK 500 PRO H 231 -178.12 -65.92 REMARK 500 VAL L 45 -54.80 -120.28 REMARK 500 ALA L 82 -169.76 -166.49 REMARK 500 LEU L 108 94.89 -62.45 REMARK 500 ASP L 153 -106.89 59.26 REMARK 500 THR L 211 42.24 -86.36 REMARK 500 GLN C 10 39.87 -78.49 REMARK 500 PRO C 23 -164.21 -67.82 REMARK 500 ASP C 48 44.52 -91.08 REMARK 500 ILE C 73 64.83 -119.61 REMARK 500 ASP C 136 86.30 -67.17 REMARK 500 GLU C 163 68.62 -69.76 REMARK 500 REMARK 500 REMARK: NULL DBREF 8TZW H 1 232 PDB 8TZW 8TZW 1 232 DBREF 8TZW L 1 212 PDB 8TZW 8TZW 1 212 DBREF 8TZW C 9 164 PDB 8TZW 8TZW 9 164 SEQRES 1 H 232 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU VAL LYS SEQRES 2 H 232 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 H 232 PHE THR PHE SER ASN ALA TRP MET SER TRP VAL ARG GLN SEQRES 4 H 232 ALA PRO GLY LYS GLY LEU GLU TRP VAL GLY ARG ILE LYS SEQRES 5 H 232 SER LYS THR ASP GLY GLY THR THR ASP TYR ALA ALA PRO SEQRES 6 H 232 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASP SER LYS SEQRES 7 H 232 ASN THR LEU TYR LEU GLN MET ASN SER LEU LYS THR GLU SEQRES 8 H 232 ASP THR ALA VAL TYR TYR CYS ALA ARG THR GLY LYS TYR SEQRES 9 H 232 TYR ASP PHE TRP SER GLY TYR PRO PRO GLY GLU GLU TYR SEQRES 10 H 232 PHE GLN ASP TRP GLY ARG GLY THR LEU VAL THR VAL SER SEQRES 11 H 232 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 12 H 232 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 13 H 232 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 14 H 232 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 15 H 232 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 16 H 232 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 17 H 232 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 18 H 232 ASN THR LYS VAL ASP LYS ARG VAL GLU PRO LYS SEQRES 1 L 212 SER GLU LEU THR GLN ASP PRO ALA VAL SER VAL ALA LEU SEQRES 2 L 212 GLY GLN THR VAL ARG ILE THR CYS GLN GLY ASP SER LEU SEQRES 3 L 212 ARG SER TYR TYR ALA SER TRP TYR GLN GLN LYS PRO GLY SEQRES 4 L 212 GLN ALA PRO VAL LEU VAL ILE TYR GLY LYS ASN ASN ARG SEQRES 5 L 212 PRO SER GLY ILE PRO ASP ARG PHE SER GLY SER SER SER SEQRES 6 L 212 GLY ASN THR ALA SER LEU THR ILE THR GLY ALA GLN ALA SEQRES 7 L 212 GLU ASP GLU ALA ASP TYR TYR CYS SER SER ARG ASP LYS SEQRES 8 L 212 SER GLY SER ARG LEU SER VAL PHE GLY GLY GLY THR LYS SEQRES 9 L 212 LEU THR VAL LEU SER GLN PRO LYS ALA ALA PRO SER VAL SEQRES 10 L 212 THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN ALA ASN SEQRES 11 L 212 LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE TYR PRO SEQRES 12 L 212 GLY ALA VAL THR VAL ALA TRP LYS ALA ASP SER SER PRO SEQRES 13 L 212 VAL LYS ALA GLY VAL GLU THR THR THR PRO SER LYS GLN SEQRES 14 L 212 SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SER LEU SEQRES 15 L 212 THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SER CYS SEQRES 16 L 212 GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS THR VAL SEQRES 17 L 212 ALA PRO THR GLU SEQRES 1 C 156 MET GLN GLY ILE HIS PHE ARG ARG HIS TYR VAL ARG HIS SEQRES 2 C 156 LEU PRO LYS GLU VAL SER GLN ASN ASP ILE ILE LYS ALA SEQRES 3 C 156 LEU ALA SER PRO LEU ILE ASN ASP GLY MET VAL VAL SER SEQRES 4 C 156 ASP PHE ALA ASP HIS VAL ILE THR ARG GLU GLN ASN PHE SEQRES 5 C 156 PRO THR GLY LEU PRO VAL GLU PRO VAL GLY VAL ALA ILE SEQRES 6 C 156 PRO HIS THR ASP GLY GLU TYR VAL ARG GLN ASN ALA ILE SEQRES 7 C 156 SER VAL GLY ILE LEU ALA GLU PRO VAL ASN PHE GLU ASP SEQRES 8 C 156 ALA THR GLY GLU PRO ASP PRO VAL PRO VAL ARG VAL VAL SEQRES 9 C 156 PHE MET LEU ALA LEU SER ASN TRP ASP ASP ILE THR ASN SEQRES 10 C 156 VAL LEU TYR TRP ILE LYS ALA VAL ILE GLN ASP GLU ASP SEQRES 11 C 156 PHE MET GLN GLN LEU LEU VAL MET ASN ASP ASP GLU ILE SEQRES 12 C 156 TYR GLN SER ILE TYR THR ARG ILE SER GLU LEU GLU HIS FORMUL 4 HOH *19(H2 O) HELIX 1 AA1 ALA H 64 LYS H 67 5 4 HELIX 2 AA2 LYS H 89 THR H 93 5 5 HELIX 3 AA3 SER H 205 GLY H 208 5 4 HELIX 4 AA4 LYS H 219 ASN H 222 5 4 HELIX 5 AA5 ASP L 24 SER L 28 5 5 HELIX 6 AA6 GLN L 77 GLU L 81 5 5 HELIX 7 AA7 SER L 123 GLN L 128 1 6 HELIX 8 AA8 THR L 183 SER L 189 1 7 HELIX 9 AA9 ARG C 15 HIS C 17 5 3 HELIX 10 AB1 SER C 27 ASP C 42 1 16 HELIX 11 AB2 ASP C 48 PHE C 60 1 13 HELIX 12 AB3 ASP C 77 VAL C 81 5 5 HELIX 13 AB4 ASN C 119 ILE C 134 1 16 HELIX 14 AB5 ASP C 136 GLN C 141 1 6 HELIX 15 AB6 ASN C 147 GLU C 161 1 15 SHEET 1 AA1 4 GLN H 3 SER H 7 0 SHEET 2 AA1 4 LEU H 18 SER H 25 -1 O SER H 25 N GLN H 3 SHEET 3 AA1 4 THR H 80 MET H 85 -1 O MET H 85 N LEU H 18 SHEET 4 AA1 4 PHE H 70 ASP H 75 -1 N THR H 71 O GLN H 84 SHEET 1 AA2 6 LEU H 11 VAL H 12 0 SHEET 2 AA2 6 THR H 125 VAL H 129 1 O THR H 128 N VAL H 12 SHEET 3 AA2 6 ALA H 94 TYR H 104 -1 N TYR H 96 O THR H 125 SHEET 4 AA2 6 TRP H 33 GLN H 39 -1 N VAL H 37 O TYR H 97 SHEET 5 AA2 6 LEU H 45 ILE H 51 -1 O ILE H 51 N MET H 34 SHEET 6 AA2 6 THR H 60 TYR H 62 -1 O ASP H 61 N ARG H 50 SHEET 1 AA3 4 LEU H 11 VAL H 12 0 SHEET 2 AA3 4 THR H 125 VAL H 129 1 O THR H 128 N VAL H 12 SHEET 3 AA3 4 ALA H 94 TYR H 104 -1 N TYR H 96 O THR H 125 SHEET 4 AA3 4 GLU H 115 TRP H 121 -1 O TYR H 117 N GLY H 102 SHEET 1 AA4 4 SER H 138 LEU H 142 0 SHEET 2 AA4 4 THR H 153 TYR H 163 -1 O LYS H 161 N SER H 138 SHEET 3 AA4 4 TYR H 194 PRO H 203 -1 O VAL H 202 N ALA H 154 SHEET 4 AA4 4 VAL H 181 THR H 183 -1 N HIS H 182 O VAL H 199 SHEET 1 AA5 4 SER H 138 LEU H 142 0 SHEET 2 AA5 4 THR H 153 TYR H 163 -1 O LYS H 161 N SER H 138 SHEET 3 AA5 4 TYR H 194 PRO H 203 -1 O VAL H 202 N ALA H 154 SHEET 4 AA5 4 VAL H 187 LEU H 188 -1 N VAL H 187 O SER H 195 SHEET 1 AA6 3 THR H 169 TRP H 172 0 SHEET 2 AA6 3 ILE H 213 HIS H 218 -1 O ASN H 215 N SER H 171 SHEET 3 AA6 3 THR H 223 ARG H 228 -1 O VAL H 225 N VAL H 216 SHEET 1 AA7 4 THR L 4 GLN L 5 0 SHEET 2 AA7 4 VAL L 17 GLN L 22 -1 O GLN L 22 N THR L 4 SHEET 3 AA7 4 THR L 68 ILE L 73 -1 O ALA L 69 N CYS L 21 SHEET 4 AA7 4 PHE L 60 SER L 65 -1 N SER L 61 O THR L 72 SHEET 1 AA8 5 ALA L 8 ALA L 12 0 SHEET 2 AA8 5 THR L 103 LEU L 108 1 O THR L 106 N VAL L 11 SHEET 3 AA8 5 ASP L 83 ARG L 89 -1 N TYR L 84 O THR L 103 SHEET 4 AA8 5 SER L 32 GLN L 36 -1 N GLN L 36 O ASP L 83 SHEET 5 AA8 5 VAL L 43 ILE L 46 -1 O ILE L 46 N TRP L 33 SHEET 1 AA9 4 ALA L 8 ALA L 12 0 SHEET 2 AA9 4 THR L 103 LEU L 108 1 O THR L 106 N VAL L 11 SHEET 3 AA9 4 ASP L 83 ARG L 89 -1 N TYR L 84 O THR L 103 SHEET 4 AA9 4 SER L 97 PHE L 99 -1 O VAL L 98 N SER L 88 SHEET 1 AB1 4 SER L 116 PHE L 120 0 SHEET 2 AB1 4 ALA L 132 PHE L 141 -1 O LEU L 137 N THR L 118 SHEET 3 AB1 4 TYR L 174 LEU L 182 -1 O ALA L 176 N ILE L 138 SHEET 4 AB1 4 VAL L 161 THR L 163 -1 N GLU L 162 O TYR L 179 SHEET 1 AB2 4 SER L 116 PHE L 120 0 SHEET 2 AB2 4 ALA L 132 PHE L 141 -1 O LEU L 137 N THR L 118 SHEET 3 AB2 4 TYR L 174 LEU L 182 -1 O ALA L 176 N ILE L 138 SHEET 4 AB2 4 SER L 167 LYS L 168 -1 N SER L 167 O ALA L 175 SHEET 1 AB3 4 SER L 155 VAL L 157 0 SHEET 2 AB3 4 VAL L 146 ALA L 152 -1 N ALA L 152 O SER L 155 SHEET 3 AB3 4 TYR L 193 HIS L 199 -1 O GLN L 196 N ALA L 149 SHEET 4 AB3 4 SER L 202 VAL L 208 -1 O VAL L 204 N VAL L 197 SHEET 1 AB4 5 VAL C 19 LEU C 22 0 SHEET 2 AB4 5 ALA C 85 PHE C 97 1 O ILE C 90 N LEU C 22 SHEET 3 AB4 5 VAL C 107 ALA C 116 -1 O ARG C 110 N LEU C 91 SHEET 4 AB4 5 GLY C 70 ALA C 72 1 N ALA C 72 O PHE C 113 SHEET 5 AB4 5 GLY C 63 LEU C 64 -1 N LEU C 64 O VAL C 71 SSBOND 1 CYS H 22 CYS H 98 1555 1555 2.03 SSBOND 2 CYS H 158 CYS H 214 1555 1555 2.04 SSBOND 3 CYS L 21 CYS L 86 1555 1555 2.04 SSBOND 4 CYS L 136 CYS L 195 1555 1555 2.04 CISPEP 1 PRO H 112 PRO H 113 0 0.30 CISPEP 2 PHE H 164 PRO H 165 0 -2.24 CISPEP 3 GLU H 166 PRO H 167 0 -2.66 CISPEP 4 TYR L 142 PRO L 143 0 -1.97 CISPEP 5 GLU C 67 PRO C 68 0 -3.36 CRYST1 71.487 70.988 73.224 90.00 107.36 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013989 0.000000 0.004373 0.00000 SCALE2 0.000000 0.014087 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014309 0.00000